Scrip
US long-acting opioid REMS at least a year away
20 October 2009
Sue Sutter
A recent US
FDA regulatory action suggests implementation of a single risk evaluation and mitigation strategy (REMS) for the class of long-acting opioids and immediate-release methadone is well over a year away.
The FDA recently published a notice reopening until October 19th, 2010, the comment...
Please Login to read the full article.
20 October 2009
Sue Sutter
The FDA recently published a notice reopening until October 19th, 2010, the comment...
Please Login to read the full article.
RELATED CONTENT
COMMENT
Other Informa Comment
FEATURES
Other Informa Features
EVENTS
01 January 1970
London, UK
01 January 1970
San Diego, US
01 January 1970
Providence, Rhode Island, and San Francisco, California
JOB OF THE WEEK
Promote your vacancy here
